Home › Amyotrophic Lateral Sclerosis › North Carolina
Amyotrophic Lateral Sclerosis clinical trials in North Carolina
9 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in North Carolina.
Cities in North Carolina
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Zydus US003, Winston-Salem
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07023835ASSESS ALL ALS Study
- Duke University, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- Duke University, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06581861ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- University of North Carolina, Chapel Hill, Chapel Hill
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04363684Intestinal Microbiome Transplant in ALS
- Duke University Medical Center, Durham
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07017946Clinical Procedures to Support Research in ALS
- Duke University, Durham
- Wake Forest University, Winston-Salem
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT03489278EIM Via the Myolex mScan as an ALS Biomarker
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT06491732Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT03233646From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.